Excessive-profile gene modifying startup Tome Biosciences mentioned in a authorized submitting Friday that it’ll terminate nearly its complete employees starting Nov. 1.
The Massachusetts WARN discover comes a day after STAT reported the corporate was in dire straits, with one supply saying that it deliberate to wind down operations and search a purchaser by Nov. 1 after the corporate struggled to boost cash or discover a associate.
Tome instructed STAT it was solely “working at lowered capability,” whereas “sustaining core experience” because it “discover[d] strategic choices.”
Get limitless entry to award-winning journalism and unique occasions.